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Abstract : Acute pancreatitis（AP）in childhood is rare, but is starting to be rec-
ognized more often.  However, optimal enteral nutrition formulas for children with 
AP have not been determined.  This report describes the successful management 
of AP, with low-fat elemental enteral nutrition, in a 5-year-old boy.  The patient 
had been diagnosed with mild AP and started oral feeding after about 3 days of 
fasting, but his pancreatic enzyme levels subsequently became elevated.  Therefore, 
to allow the pancreas to rest, total parenteral nutrition（TPN）was started.  After 
starting TPN, there was no improvement in his pancreatic enzyme levels but, 
because his clinical symptoms were stable, a small amount of elemental diet was 
initiated.  Elemental diet therapy was safely performed without return of any clini-
cal symptoms and the patient’s pancreatic enzyme levels slowly improved.  Elemen-
tal diet was both safe and benecial, providing clinical remission and improvement 
in quality of life.  Early elemental diet therapy may therefore be a useful treat-
ment strategy for pediatric patients with AP.
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Introduction
　Nutritional support is important in the management of acute pancreatitis（AP）, and is 
comparable to medical therapies such as proteolytic enzyme agents, particularly in children.  As 
reported in guidelines on nutrition in AP1-4）, sufficient energy and nutrients should be provided 
after fasting in the acute disease phase, via an optimal route that depends on the pathological 
severity of the disease.  It has been reported that 70％ of patients receive oral feeding at 
admission, 20％ receive total parental nutrition（TPN）, and only 3％ receive enteral feeding. 
Infants and toddlers are much more likely to receive TPN than older children （64％ vs 17％）5）. 
Nutritional intervention is required in patients with malnutrition or inadequate oral ingestion. 
Moreover, some recent reports suggest that early oral or enteral feeding should be started within 
a few days if patients with AP achieve pain relief and improved gastrointestinal function1）. 
Nevertheless, the optimal nutritional approach for children is unclear.
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　We used a low-fat elemental diet（ED） as nutritional intervention in a 5-year-old boy 
with mild AP.  We administered the low-fat ED orally, without using tube devices, and this 
maintained clinical remission and improved our patient’s quality of life.
Case Report
　A 5-year-old Japanese boy was admitted to hospital 3 days after onset of illness.  He had 
developed several digestive symptoms : mild abdominal pain, vomiting a small amount of yellow 
liquid, a fever of 38.9°C, headache, dehydration, weight loss, and fatigue.  On examination, 
delayed growth was observed（his height was 2.5 standard deviations below the mean height 
for age and weight was 1.0 standard deviation below the mean weight for age）but no 
developmental retardation or anomalies were observed.  He had previously visited a pediatric 
clinic for investigation of short stature, but no causes were found.  His characteristics on 
admission are shown in Table 1.
　The patient was diagnosed with mild AP according to the INSPIRE criteria, as shown in 
Table 2 6）.  Diagnostic imaging showed no abnormalities, so the case was classified as idiopathic 
AP.  The patient was administered gabexate mesilate, famotidine and cefotiam hydrochloride 
while fasting.  When oral re-feeding was started after 3 days of fasting （day 7）, the patient’s 
pancreatic enzyme levels became elevated （Fig. 1 and Table 3）.  His maximal daily energy and 
Table 1.  Patient characteristics on admission to hospital
Clinical parameters Biochemical parameters
Age 5 years Total protein 6.6 g / dl
Gender Male Albumin 4.4 g / dl
Body weight 15.6 kg Aspartate aminotransferase 58 IU / l
Body height 98 cm Alanine aminotransferase 28 IU / l
Body mass index 16.2 kg / m2 Lactate dehydrogenase 296 mg / dl
Alkaline phosphatase 380 mg / dl
Hematological parameters Total bilirubin 0.7 mg / dl
White blood cell count 8,100 / µl Urea nitrogen 17 mg / dl
Red blood cell count 4,810 × 103 / µl Creatinine 0.36 mg / dl
Hemoglobin 13.5 g / dl Sodium 131.7 mEq / l
Hematocrit 40.1％ Potassium 4.3 mEq / l
Platelet 230 × 103 / µl Chloride 95 mEq / l
pH 7.272 Calcium 9 mg / dl
PaO2 40.4 mmHg Creatinine kinase 80 IU / l
PaCO2 40.3 mmHg Total cholesterol 150 mg / dl
HCO3- 17.3 mEq / l Triglyceride 73 mg / dl
Base excess –8.2 mEq / l Glucose 68 mg / dl
SaO2 68.8％ C-reactive protein 1.4 mg / dl
p-Amylase 582 IU / l
Lipase 438 IU / l
Trypsin 4,500 ng / ml
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Fig. 1.  Changes in plasma amylase and lipase levels during hospitalization and after discharge
Table 3.  Clinical and biochemical parameters for our patient during hospital admission and after discharge
Days after onset of symptoms After discharge
4 7 11 16 19 26 37 44 47 186 380 
p-Amylase （IU / l） 582  86 177 373 210 172 224 224 220 195 136
Lipase （IU / l） 438 185 245 410 246 193 246 227 214 293  45
CRP （mg / dl） 1.4 - - 0.1 0.1 N.D. N.D. N.D. N.D. N.D N.D
Albumin （g / dl） 4.4 - - 4.3 4.0 4.2 4.3 4.2 4.5 4.6 4.8
Total 
Cholesterol （mg / dl） 140 150 - 148 131 89 197 139 123 156 173
Body weight （kg） 15.6 15.5 15.1 14.1 14.4 14.8 15.4 15.5 - 16 17.5
Body height （cm） 98.0 103.9
N.D., not detected.
Table 2.  Application of INSPIRE criteria for diagnosis of acute pancreatitis in our patient
Acute pancreatitis criteria（at least 2 out of 3 required for diagnosis） Criterion met in our patient
Abdominal pain suggestive of, or compatible with AP（ie, abdominal 
pain of acute onset, especially in the epigastric region）
Yes
Serum amylase and / or lipase activity at least 3 times greater than the 
upper limit of normal（IU / l）
Yes
Imaging findings characteristic of, or compatible with AP＊ No
＊ For example, using transabdominal ultrasonography, contrast-enhanced computed tomography, endo-
scopic ultrasonography, magnetic resonance imaging or magnetic resonance cholangiopancreatography.
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fat intake were 739 kcal and 10.7 g, respectively（Fig. 2）.  Feeding was stopped again on day 18. 
The patient was given TPN to allow the pancreas to rest, because post-pyloric tube feeding can 
be distressing for pediatric patients.  His clinical symptoms stabilized, so nutritional management 
with oral ED was initiated, and followed by additional oral diet（day 24）, to enable withdrawal 
and discontinuation of TPN.  The ED（Elental; EA Pharma Co., Ltd.  Tokyo, Japan）contained 
amino acids（17.6％）, dextrin（79.3％）, lipids（0.6％）, minerals（2.0％）, and vitamins（0.5％）, and 
provided 1 kcal/ml, 0.05 g / ml protein, and 1.7 mg / ml lipids（Table 4）.  It did not contain fiber, 
carnitine or selenium.
　After starting the ED combined with an oral diet, the patient’s total daily energy intake was 
increased to 1,033 kcal / day and his fat intake was 8.5 g / day.  The ED provided approximately 
300 kcal / day without exacerbating pancreatitis-related symptoms or increasing pancreatic enzyme 
levels（Fig. 1 and Table 3）.  The ED therapy made it possible to provide sufficient energy 
while restricting fat intake.  We were able to withdraw the patient from TPN on day 38 and 
discharge him from hospital on day 48.  After discharge, he continued ED therapy at home. 
He has reported no further clinical symptoms for more than 1 year, and his clinical laboratory 
Fig. 2.  Energy intake and lipid intake 
（A） Nutrition management and energy intake during hospitalization.
（B） Daily fat intake from meals during hospitalization – from ED, from oral feeding and total.
PPN, peripheral parenteral nutrition；TPN, total parenteral nutrition.
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data have not been exacerbated.  He has maintained good nutritional status according to his 
serum albumin and total cholesterol levels（Table 3）.  He has grown in keeping with his height 
standard deviation（Fig. 3）.
Discussion
　Several reports have indicated that nutritional management is an efficacious and cost-effective 
strategy for the treatment of AP7, 8）.  The issues that should be considered during the nutritional 
management of AP are : optimal timing of the nutritional therapy, optimal feeding route（oral, 
gastric, jejunal, or parenteral）, and optimal nutrient formulation（elemental, semi-elemental, 
Table 4.  Composition of the elemental diet used to manage acute pancreatitis in our patient
Total 80 g（300 kcal） Amino acids 13.14 g
Amino acids 13.14 g L-Isoleucine 642 mg
Carbohydrate （dextrin） 63.41 g L-Leucine 899 mg
Lipid （soybean oil） 0.51 g L-Lysine・HCl 888 mg
Vitamin A 223.2 µg  （648 IU） L-Methionine 648 mg
Vitamin D 1.3 µg  （51.2 IU） L-Phenylalanine 871 mg
Vitamin B1 152 µg L-Threonine 523 mg
Vitamin B2 244 µg L-Tryptophan 151 mg
Vitamin B6 220 µg L-Valine 701 mg
Vitamin B12 0.72 µg L-Histidine・HCl・H2O 501 mg
Niacin 2.20 mg L-Arginine・HCl 1,125 mg
Pantothenic acid 1.10 mg L-Alanine 899 mg
Folic acid 44 µg Mg・K・L-Aspartate 1,036 mg
Vitamin C 7.80 mg Na・L-Aspartate・H2O 867 mg
Vitamin K 9 µg L-Glutamine 1,932 mg
Vitamin E 3.3 mg   （3.3 IU） Glycine 505 mg
Biotin 39 µg L-Proline 630 mg
Choline 8.56 mg L-Serine 1,159 mg
Na 260.0 mg（11.3 mEq） L-Tyrosine 110 mg
K 217.6 mg（5.6 mEq）
Cl 516.8 mg（14.6 mEq）
Mg 40.0 mg（3.3 mEq）
Ca 157.6 mg（7.9 mEq）
P 121.6 mg（3.9 mmol）
Fe 1.8 mg（32.2 µmol）
I 15.2 µg（0.1 µmol）
Mn 0.3 mg（5.5 µmol）
Cu 0.2 mg（3.2 µmol）
Zn 1.8 mg（27.5 µmol）
The diet was prepared by dissolving 80 g of the elemental diet in 300 ml of cold or 
lukewarm drinking water（1 kcal / ml）.  The solution was administered orally once daily or 
divided into several portions per day.  In cases of tube feeding, the solution is adminis-
tered into the duodenum or jejunum continuously over 24 hr via a nasogastric tube or a 
gastric or intestinal stula（at an injection rate of 75-100 ml / hr）.
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polymetric, immune-enhancing, and prebiotics and probiotics）1, 9, 10）.  Few reports and guidelines 
on nutritional management of pediatric patients with AP have been published4）.  Because 
children require high energy and nutrition for growth, children with AP are at risk of acute 
malnutrition because of the energy and nutrition deficiencies caused by the catabolic state of the 
disease and treatment using oral food restriction11）.  It is extremely important to supply sufficient 
energy and nutrients according to the condition of the patient.
　The causes of AP differ between pediatric and adult patients12）.  The cause of the disease 
in our patient was not identified from his anamnesis, medical history, diagnostic imaging, 
or biochemical analysis.  Therefore, he was diagnosed with idiopathic disease.  Nutritional 
management was necessary to improve his nutritional status and achieve normal growth.
　According to the European Society for Clinical Nutrition and Metabolism guidelines, parenteral 
nutrition is required only when the gut has failed or enteral nutrition is impossible for other 
reasons（eg, because hypoalimentation will cause protein catabolism and may worsen prognosis）. 
Nutritional support therapy is not always required in cases of mild-to-moderate AP, but it is 
required when an unexpected complication develops or when advancing to an oral diet within 
7 days is not possible.  In patients stabilized on parenteral nutrition, repeated efforts should be 
periodically conducted to initiate enteral nutrition1）.  Kumar and Gariepy have reported that oral 
nutrition is well tolerated in patients with mild disease and that such treatment strategies may be 
beneficial in children with AP, on a case-by-case basis13）.
　In our patient’s case, it was possible to switch to oral feeding using a low-fat diet after 
fasting for about 3 days because his symptoms were not severe and clinical improvements 
were observed during fasting.  However, clinical laboratory data indicated that his condition 
was exacerbated after starting ingestion, so we needed to stop oral feeding.  We first 
performed peripheral parenteral nutrition（PPN） under fasting conditions.  However, the energy 
Fig. 3.    Height-for-age and weight-for-age percentiles for boys aged 
0–18 years, showing the growth curve for our patient
（indicated by thick lines beginning with a filled circle）.
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requirements of the patient were approximately 1,300 kcal / day, and the energy provided by 
PPN was insufficient.  The patient was malnourished, so temporary TPN was selected to avoid 
nutritional depletion, instead of post-pyloric tube feeding（to avoid distress）.  The exacerbation 
observed after the oral re-feeding with a low-fat diet may have been because the re-feeding was 
initiated too soon or because the diet contained an inappropriate amount of fat.  Therefore, we 
stopped the feeding and started oral administration of a low-fat ED containing amino acids after 
the temporary TPN therapy.  We progressively increased nutritional support to the patient and 
added a low-fat diet.
　Other authors have reported that initiating oral feeding at an early stage may stimulate 
pancreatic secretion, and cause recurrence of pain14）.  Teich et al reported that normalization of 
serum lipase levels was not required for enteral nutrition in patients with mild AP 15）.  
　Meng et al indicated that a non-liquid（soft）diet did not increase pain recurrence after 
re-feeding16）.  Elemental formulas（containing individual amino acids and almost no fat）cause 
less stimulation of the pancreas than standard formulas with intact proteins and long-chain fatty 
acids, because an ED stimulates only low levels of cholecystokinin secretion17）.  However, long-
term fat restriction with nutritional management strategies such as ED or TPN without lipid 
emulsion may lead to essential fatty acid deficiency – after 2 weeks in pediatric patients, and 
after 4 weeks in adult patients18）.  Thus, when AP needs to be managed over a long period, 
essential fatty acid supplementation, such as lipid emulsion infusion, should be considered.  The 
ED that we used to treat our patient（Elental, Table 4）is a suitable formulation for patients 
with AP15）.  The ED is a transintestinal high-calorie diet that can be absorbed easily with little 
residue or fat.  Therefore, oral ED is a physiological method of providing more calories during 
the early phase of mild pediatric AP.  Although there are no clear recommendations regarding 
the daily fat intake or fat restriction targets in pediatric AP, the fat intake in the current patient 
was 8.5 g / day during oral ED therapy（total 1,033 kcal / day）.  This was adequately low to 
maintain his pancreatic enzyme levels and provide sufficient total energy.
Conclusion
　Nutritional management combining ED with oral feeding in our patient（including ED therapy 
at home after discharge from hospital）was safe, maintained clinical remission, and improved 
our patient’s quality of life.  Further prospective clinical studies are necessary to better define 
optimal nutritional management of pediatric AP.
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